Development of sequence specific radioimmunoassay of human parathyroid hormone and its use in the diagnosis of hyperparathyroidism
- 1 January 1979
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Clinical and Laboratory Investigation
- Vol. 39 (5) , 469-478
- https://doi.org/10.3109/00365517909106133
Abstract
Two antisera which were raised against bovine parathyroid hormone (bPTH) and which cross-reacted with the human hormone were characterized. The antisera which originated from rooster and guinea pig contained several populations of antibodies directed against N-terminal and C-terminal sequences of the hormone. At proper dilutions the rooster antiserum did not bind the N-terminal fragment nor could this fragment displace the [125I]bPTH (1-84 amino acid residue) from binding to the antiserum. Preincubation experiments with excess N-terminal fragment showed only a negligible reduction in maximal binding of the iodinated intact hormone using the rooster antiserum. In contrast, the guinea pig antiserum reacted equally well with the N-terminal fragment and the intact hormone and preincubation with this fragment reduced the binding of the [125I]bPTH (1-84 amino acid residues) by 75%. Gel filtration of hyperparathyroid serum on Bio-Gel P-60 showed immunoreactive material which was measured with both antisera, eluting at a position similar to the intact hormone. In the C-terminal specific, but not in the N-terminal specific radioimmunoassay [RIA] the major component eluted together with or somewhat earlier than the N-terminal bPTH fragment (1-34 amino acid residue); this peak represented more than 90% of total immunoreactive PTH (iPTH) in serum. This major iPTH component must therefore represent fragment(s) with intact carboxy-terminal sequences. The N-terminal specific RIA was unable to measure iPTH in about 80-90% of healthy individuals, while the C-terminal specific assay detected iPTH in about 88% of these sera (equal to or above 0.1 .mu.g/l). Similarly, the N-terminal specific antiserum measured consistently lower serum iPTH concentrations in patients with primary hyperparathyroidism. In 34 of 41 patients with surgically verified primary hyperparathyroidism, serum iPTH concentrations equal to or above 0.60 .mu.g/l were demonstrated using the C-terminal, specific RIA.This publication has 15 references indexed in Scilit:
- Carboxyl-Terminal Fragments of Human Parathyroid Hormone in Parathyroid Tumors: Unique New Source of Immunogens for the Production of Antisera Potentially Useful in the Radioimmunoassay of Parathyroid Hormonein Human Serum*Journal of Clinical Endocrinology & Metabolism, 1978
- Parathyroid Hormone Secretion in Primary HyperparathyroidismJournal of Clinical Endocrinology & Metabolism, 1977
- REGION-SPECIFIC IMMUNOASSAYS FOR PARATHYROID HORMONEJournal of Endocrinology, 1975
- Immunoreactive Forms of Circulating Parathyroid Hormone in Primary and Ectopic HyperparathyroidismJournal of Clinical Investigation, 1974
- Parathyroid Hormone in Human PlasmaJournal of Clinical Investigation, 1972
- Multiple Immunoreactive Molecular Forms of Parathyroid Hormone in Human SerumExperimental Biology and Medicine, 1972
- Radioimmunoassay of human parathyroid hormone in serumJournal of Clinical Investigation, 1971
- Primary HyperparathyroidismNew England Journal of Medicine, 1969
- IMMUNOASSAY OF BOVINE AND HUMAN PARATHYROID HORMONEProceedings of the National Academy of Sciences, 1963
- THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONSAnnals of the New York Academy of Sciences, 1949